More on RARE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.1 Score)
- Holders
- FDA Archive

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ultragenyx Pharma (NQ:RARE)
Delayed: 27.44 +0.53 (1.97%)
Prev. Close $26.91  
Open$27.54 
52 Wk High$117.12 
52 Wk Low$46.52 
Day High$28.18 
Day Low$27.31 
P/E N/A  
EPS$-1.97 
Volume3,562,450 

Friends, Peers and Foes (?): MREO, ACLX, AGIO, AKRO, ASND (more...)

Jun 19, 2026 04:30 PM Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 15, 2026 06:51 PM Form 4 Ultragenyx Pharmaceutica For: Jun 15 Filed by: Sanders Corazon (Corsee) D.
Jun 15, 2026 06:46 PM Form 4 Ultragenyx Pharmaceutica For: Jun 15 Filed by: Parschauer Karah Herdman
Jun 15, 2026 04:51 PM Form 144 Ultragenyx Pharmaceutica Filed by: Parschauer Karah Herdman
Jun 15, 2026 04:12 PM Form 144 Ultragenyx Pharmaceutica Filed by: Sanders Corazon (Corsee) D.
Jun 12, 2026 01:40 PM Form S-8 Ultragenyx Pharmaceutica
Jun 3, 2026 04:30 PM Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
Jun 1, 2026 07:12 PM Form 4 Ultragenyx Pharmaceutica For: Jun 01 Filed by: Horn Howard
Jun 1, 2026 04:09 PM Form 144 Ultragenyx Pharmaceutica Filed by: Horn Howard
May 22, 2026 04:30 PM Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with RARE

View All Entities